Lgals3 - lectin, galactose binding, soluble 3 Gene
Also Known as GBP; L-34; gal3; Mac-2
Species: Mus musculus
Summary
Predicted to enable several functions, including IgE binding activity; advanced glycation end-product receptor activity; and signaling receptor binding activity. Involved in negative regulation of T cell receptor signaling pathway; negative regulation of endocytosis; and negative regulation of lymphocyte activation. Acts upstream of or within extracellular matrix organization and skeletal system development. Located in several cellular components, including external side of plasma membrane; glial cell projection; and immunological synapse. Is expressed in several structures, including alimentary system; genitourinary system; respiratory system; skeleton; and skin. Used to study fatty liver disease. Human ortholog(s) of this gene implicated in asthma. Orthologous to human LGALS3 (Galectin 3). [provided by Alliance of Genome Resources, Apr 2022]
Lgals3 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001145953.1 | NP_001139425.1 | galectin-3 |
| NM_010705.3 | NP_034835.1 | galectin-3 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
10745073 | MGI |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| acts upstream of or within extracellular matrix organization |
IGI
IGI: Inferred from genetic interaction
|
15800063 | MGI |
| NOT involved in maintenance of protein location |
IDA
IDA: Inferred from direct assay
|
21670307 | MGI |
| involved in negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
IMP
IMP: Inferred from mutant phenotype
|
19706535 | MGI |
| involved in negative regulation of T cell receptor signaling pathway |
IMP
IMP: Inferred from mutant phenotype
|
19706535 | MGI |
| involved in negative regulation of endocytosis |
IMP
IMP: Inferred from mutant phenotype
|
19706535 | MGI |
| involved in negative regulation of immunological synapse formation |
IMP
IMP: Inferred from mutant phenotype
|
19706535 | MGI |
| acts upstream of or within skeletal system development |
IGI
IGI: Inferred from genetic interaction
|
15800063 | MGI |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cell surface |
IDA
IDA: Inferred from direct assay
|
23576987 | MGI |
| is active in cornified envelope |
IDA
IDA: Inferred from direct assay
|
26644517 | MGI |
| located in cytoplasm |
IDA
IDA: Inferred from direct assay
|
10745073 | MGI |
| located in external side of plasma membrane |
IDA
IDA: Inferred from direct assay
|
23460747 | MGI |
| located in extracellular matrix |
IDA
IDA: Inferred from direct assay
|
15800063 | MGI |
| located in glial cell projection |
IDA
IDA: Inferred from direct assay
|
20826656 | MGI |
| located in immunological synapse |
IDA
IDA: Inferred from direct assay
|
19706535 | MGI |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
10745073 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
galectin-3 |
|
|
Recombinant Lgals3 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P77684 | Galectin-3/LGALS3 Protein, Mouse (HEK293, His) | P16110 (A2-I264) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P79079 | Galectin-3/LGALS3 Protein, Mouse | NP_034835.1 (A2-I264) | ≥ 95%, as determined by reducing SDS-PAGE. |